The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Chemotaxis of primitive hematopoietic cells in response to stromal cell–derived factor-1
Open accessAbstract
Stromal cell-derived factor-1 (SDF-1) provides a potent chemotactic stimulus for CD34(+) hematopoietic cells. We cultured mobilized peripheral blood (PB) and umbilical cord blood (CB) for up to 5 weeks and examined the migratory activity of cobblestone area-forming cells (CAFCs) and long-term culture-initiating cells (LTC-ICs) in a transwell assay. In this system, SDF-1 or MS-5 marrow stromal cells placed in the lower chamber induced transmembrane and transendothelial migration by 2- and 5-week-old CAFCs and LTC-ICs in 3 hours. Transmigration was blocked by preincubation of input CD34(+) cells with antibody to CXCR4. Transendothelial migration of CB CAFCs and LTC-ICs was higher than that of PB. We expanded CD34(+) cells from CB in serum-free medium with thrombopoietin, flk-2 ligand, and c-kit ligand, with or without IL-3 and found that CAFCs cultured in the absence of IL-3 had a chemotactic response equivalent to noncultured cells, even after 5 weeks. However, addition of IL-3 to the culture reduced this response by 20-50%. These data indicate that SDF-1 induces chemotaxis of primitive hematopoietic cells signaling through CXCR4 and that the chemoattraction could be downmodulated by culture ex vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482
Cited by
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,751
Self-citationTargeting of CD44 eradicates human acute myeloid leukemic stem cells
Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F., & Dick, J. E. (2006) · Nature Medicine · doi:10.1038/nm1483 · Cited by 1,219
Broxmeyer, H. E., Orschell, C. M., Clapp, D. W., Hangoc, G., Cooper, S., Plett, P. A., Liles, W. C., Li, X., Graham-Evans, B., Campbell, T. B., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041385 · Cited by 970
Galiano, R. D., Tepper, O. M., Pelo, C. R., Bhatt, K. A., Callaghan, M., Bastidas, N., Bunting, S., Steinmetz, H. G., & Gurtner, G. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63754-6 · Cited by 798
Lévesque, J.-P., Hendy, J., Takamatsu, Y., Simmons, P. J., & Bendall, L. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15994 · Cited by 761
The immune system and cardiac repair
FRANGOGIANNIS, N. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.007 · Cited by 641
Ponomaryov, T., Peled, A., Petit, I., Taichman, R. S., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Magerus, A., Caruz, A., Fujii, N., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10329 · Cited by 584
Hattori, K., Heissig, B., Tashiro, K., Honjo, T., Tateno, M., Shieh, J.-H., Hackett, N. R., Quitoriano, M. S., Crystal, R. G., Rafii, S., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3354 · Cited by 530
Self-citationDe Falco, E., Porcelli, D., Torella, A. R., Straino, S., Iachininoto, M. G., Orlandi, A., Truffa, S., Biglioli, P., Napolitano, M., Capogrossi, M. C., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4423 · Cited by 521
Salvucci, O., Yao, L., Villalba, S., Sajewicz, A., Pittaluga, S., & Tosato, G. (2002) · Blood · doi:10.1182/blood.v99.8.2703 · Cited by 347
Aicher, A., Heeschen, C., Sasaki, K.-I., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2006) · Circulation · doi:10.1161/circulationaha.106.628623 · Cited by 316
Hiasa, K.-I., Ishibashi, M., Ohtani, K., Inoue, S., Zhao, Q., Kitamoto, S., Sata, M., Ichiki, T., Takeshita, A., & Egashira, K. (2004) · Circulation · doi:10.1161/01.cir.0000128213.96779.61 · Cited by 308
MOORE, M. A. S., HATTORI, K., HEISSIG, B., SHIEH, J. ‐., DIAS, S., CRYSTAL, R. G., & RAFII, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03572.x · Cited by 289
Self-citationThe Mechanistic Basis of Infarct Healing
Frangogiannis, N. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1907 · Cited by 288
CXCR4: chemokine receptor extraordinaire
Murdoch, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17715.x · Cited by 284
The expression and function of chemokines involved in CNS inflammation
Ubogu, E. E., Cossoy, M. B., & Ransohoff, R. M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.002 · Cited by 278
Chemokines in ischemia and reperfusion
Frangogiannis, N. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0022 · Cited by 276
Santiago, J., Dangerfield, A. L., Rattan, S. G., Bathe, K. L., Cunnington, R. H., Raizman, J. E., Bedosky, K. M., Freed, D. H., Kardami, E., & Dixon, I. M. C. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22280 · Cited by 269
Intraarterial Injection of Muscle-Derived Cd34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice
Torrente, Y., Tremblay, J.-P., Pisati, F., Belicchi, M., Rossi, B., Sironi, M., Fortunato, F., El Fahime, M., D'Angelo, M. G., Caron, N. J., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.2.335 · Cited by 262
CXCR4/CXCL12 expression and signalling in kidney cancer
Schrader, A. J., Lechner, O., Templin, M., Dittmar, K. E. J., Machtens, S., Mengel, M., Probst-Kepper, M., Franzke, A., Wollensak, T., Gatzlaff, P., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600221 · Cited by 254
Schuringa, J. J., Chung, K. Y., Morrone, G., & Moore, M. A. S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041024 · Cited by 140
“CD34 cells ( 95% pure) were derived from CB using MiniMACS (Miltenyi Biotec) as described previously (31).”
MethodSelf-citationThe role of chemoattraction in cancer metastases
Moore, M. A. S. (2001) · BioEssays · doi:10.1002/bies.1095 · Cited by 138
Self-citationChemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair
Li, M., Hale, J. S., Rich, J. N., Ransohoff, R. M., & Lathia, J. D. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.003 · Cited by 104
Neutrophil Gelatinase B and Chemokines in Leukocytosis and Stem Cell Mobilization
Starckx, S., Van den Steen, P. E., Wuyts, A., Van Damme, J., & Opdenakker, G. (2002) · Leukemia & Lymphoma · doi:10.1080/10428190290005982 · Cited by 49
Rozenveld-Geugien, M., Baas, I. O., van Gosliga, D., Vellenga, E., & Schuringa, J. J. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.02.006 · Cited by 19
Metadata
- Authors
- Jo, D.-Y., Rafii, S., Hamada, T., & Moore, M. A. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-01-01
- Volume
- 105
- Issue
- 1
- Pages
- 101-111
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2160509246
- Cited by
- 246
- References
- 1
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.